Suppr超能文献

鼾症对糖尿病患者微量白蛋白尿的影响。

Influence of snoring on microalbuminuria in diabetic patients.

机构信息

Department of Pulmonology, Fatih University, Ankara, Turkey.

出版信息

Sleep Breath. 2011 Sep;15(3):295-300. doi: 10.1007/s11325-010-0380-1. Epub 2010 Jul 6.

Abstract

OBJECTIVE

Obstructive sleep apnea (OSA) and snoring are known independent risk factors for insulin resistance. Microalbuminuria is an early marker of diabetic nephropathy and an independent risk factor for cardiovascular disease. The aim of our study was to search the prevalence of self-reported snoring and high-risk pre-test OSA diagnosis in diabetic patients and search the influence of snoring on microalbuminuria.

METHODS

A total of 237 diabetic patients (mean age, 58.6 ± 12.4 years; 126 males), were asked to complete the Berlin Questionnaire that includes questions about snoring, witnessed apnea, tiredness, history of high blood pressure and/or BMI < 30 kg/m(2). Also, their past and current medical records were reviewed for their medications, diabetic control, and complications like neuropathy, retinopathy, and microalbuminuria.

RESULTS

According to the Berlin Questionnaire, a high pre-test probability for the diagnosis of OSA was found in 47.3% of the patients. Snoring was detected in 60.3% of the patients. The mean Epworth Sleepiness Scale score was 7.8 ± 4.6 and 31.6% of the patients reported excessive daytime sleepiness. We found that the both BMI and waist circumferences were significantly associated with snoring and high-risk pre-test OSA. There were no differences for age, gender, fasting glucose, HbA1c, and lipid panels between snorers and non-snorers, and between high-risk pre-test OSA and low-risk pre-test OSA patients. Microalbuminuria was significantly more common in patients who snore. Although snoring was independently associated with microalbuminuria, there were no differences between groups for other microvascular diabetic complications.

CONCLUSION

Prevalence of OSA-related symptoms was very common in diabetic patients and further prospective studies are needed to elucidate the role of OSA's effect on diabetic control and complications.

摘要

目的

阻塞性睡眠呼吸暂停(OSA)和打鼾是已知的胰岛素抵抗的独立危险因素。微量白蛋白尿是糖尿病肾病的早期标志物,也是心血管疾病的独立危险因素。我们的研究目的是调查糖尿病患者中自我报告的打鼾和高危预测试 OSA 诊断的患病率,并探讨打鼾对微量白蛋白尿的影响。

方法

共纳入 237 名糖尿病患者(平均年龄 58.6±12.4 岁;男性 126 名),要求他们完成柏林问卷,其中包括关于打鼾、目击呼吸暂停、疲劳、高血压史和/或 BMI<30kg/m²的问题。此外,还回顾了他们的既往和当前病历,以了解他们的药物治疗、糖尿病控制情况以及神经病变、视网膜病变和微量白蛋白尿等并发症的情况。

结果

根据柏林问卷,47.3%的患者存在高预测试 OSA 诊断的可能性。60.3%的患者有打鼾。Epworth 嗜睡量表评分平均为 7.8±4.6,31.6%的患者报告白天过度嗜睡。我们发现,BMI 和腰围均与打鼾和高预测试 OSA 显著相关。打鼾者和非打鼾者、高预测试 OSA 患者和低预测试 OSA 患者之间的年龄、性别、空腹血糖、HbA1c 和血脂谱均无差异。有打鼾的患者微量白蛋白尿明显更常见。尽管打鼾与微量白蛋白尿独立相关,但其他微血管糖尿病并发症在各组之间无差异。

结论

糖尿病患者中 OSA 相关症状的患病率非常高,需要进一步的前瞻性研究来阐明 OSA 对糖尿病控制和并发症的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验